This information was published on 2026-07-27T08:14:37 for IP Right Registration Published.
| Field | Value |
| (210) | 2649958 (IR 1914246) |
| (220) |
18 Mar 2026
|
| (300) |
DK, 19 Sep 2025, VA 2025 01551
|
| (511) (510) |
Class 5
Pharmaceutical preparations, namely for treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); medical preparations, namely for treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); pharmaceutical preparations, namely for treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia; medical preparations for the treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia. Class 10 Devices for introducing pharmaceutical preparations, namely for treatment and prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS), and parts and fittings therefor; devices for introducing pharmaceutical preparations, namely for treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia, and parts and fittings therefor. Class 44 Medical and pharmaceutical services, namely in relation to treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); medical and pharmaceutical advice, namely in relation to treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); medical and pharmaceutical services, namely in relation to treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia; medical and pharmaceutical advice, namely in relation to treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia. |
| (540) | CHIRLOYO |
| (550) | Word |
| (730) |
ZEALAND PHARMA A/S
|
Find out more about publications on the About page.